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OphthalmicManifestations of Congenital Zika Syndrome
in Colombia and Venezuela
Juan B. Yepez, MD; Felipe A. Murati, MD; Michele Pettito, MD; Carlos F. Peñaranda, MD; Jazmin de Yepez, MD;
Gladys Maestre, MD; J. Fernando Arevalo, MD; for The Johns Hopkins Zika Center
IMPORTANCE The ocular manifestations and sequelae of Zika virus infection are not well
known. Recently, theWorld Health Organization changed the declaration of Zika as a public
health emergency and designated the viral outbreak and relatedmicrocephaly clusters as a
long-term program of work. This change indicates the urgent need to evaluate and document
ophthalmic manifestations in patients for timely management of this disease. In addition,
confirmation whether the public health problem in Brazil extends to other regions in South
America is needed.
OBJECTIVE To report the ocular manifestations of congenital Zika syndromewith
microcephaly in Colombia and Venezuela.
DESIGN, SETTING, AND PARTICIPANTS This prospective case series included 43 patients from
2 ophthalmic centers in Colombia and Venezuela who underwent evaluation fromOctober 1,
2015, through June 30, 2016, and were clinically diagnosed with congenital Zika syndrome.
Twenty patients were Hispanic; 13, African; 8, white; and 2, Native American.
INTERVENTIONS Ophthalmic and systemic evaluations and serologic testing were performed
on all infants. Patients underwent external ocular examination and dilated ophthalmoscopy.
Serologic testing ruled out toxoplasmosis, rubella, cytomegalovirus, syphilis, and human
immunodeficiency virus.
MAIN OUTCOMES ANDMEASURES Ophthalmicmanifestations of congenital Zika syndrome.
RESULTS Of the 43 patients included in this series (28 female and 15 male), the mean (SD) age
at examination was 2.1 (1.5) months. Themothers of all the children had no ophthalmic
findings and did not report ocular symptoms during pregnancy. All patients had bilateral
ophthalmic manifestations. Optic nerve findings included hypoplasia with the double-ring
sign, pallor, and increased cup-disc ratio in 5 patients (11.6%). Macular abnormalities included
mild to severe pigment mottling in 27 patients (63%) and lacunar maculopathy in 3 (6.9%).
Chorioretinal scarring was present in 3 patients (7%). Eleven patients (26%) had a
combination of lesions in the posterior pole. Five patients (12%) were diagnosed with
congenital glaucoma, characterized by the clinical triad of epiphora, photophobia, and
blepharospasm; increased intraocular pressure; corneal clouding at birth; and buphthalmos.
These data reveal that 12% (95% CI, 5%-24%) of cases of congenital Zika with microcephaly
had anterior segment abnormalities and 88% (95% CI, 76%-94%) had important macular
and optic nerve abnormalities. The visual sequelae of these ophthalmic manifestations
remain unknown.
CONCLUSIONS AND RELEVANCE Congenital Zika syndrome in the current study had severe
ocular abnormalities, and all patients had bilateral involvement. Ocular findings were focal
macular pigment mottling, chorioretinal atrophy with a predilection for themacular area,
congenital glaucoma and optical nerve hypoplasia, and optic disc abnormalities. Ophthalmic
examination is recommended in patients with congenital Zika syndrome.
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Published online April 13, 2017.
CMEQuiz at
jamanetwork.com/learning
and CMEQuestions page 508
Author Affiliations:Author
affiliations are listed at the end of this
article.
Group Information:Members of The
Johns Hopkins Zika Center are listed
at the end of the article.
Corresponding Author: J. Fernando
Arevalo, MD, Retina Division, Wilmer
Eye Institute, Johns Hopkins
University School of Medicine, 600 N
Wolfe St, Maumenee 708, Baltimore,
MD 21287 (arevalojf@jhmi.edu).
Research
JAMAOphthalmology | Original Investigation
440 (Reprinted) jamaophthalmology.com
Downloaded From: https://jamanetwork.com/ by a University of Texas - Rio Grande Valley User  on 02/06/2020
Copyright 2017 American Medical Association. All rights reserved.
T he Zika virus was isolated in monkeys in the UgandanZika forest in the 1940s1 and identified inhumans in the1950s in Africa.2 For most of the 21st century, Zika vi-
rus infection was extremely rare outside Africa. This relative
obscurity was attributable to the lower prevalence and simi-
larity of Zikavirus infection toothermore commonmosquito-
borne flaviviruses such as dengue and chikungunya. An epi-
demicof Zikavirusoccurred inMicronesia in2007,whichwas
the first outbreak outside Africa.3 The epidemic was consid-
ered tobebenignbecausemostof the infections (80%)yielded
only mild symptoms that were reminiscent of the better-
knowndengueor chikungunya, including rash, fever, arthral-
gia, headaches, and conjunctivitis. The duration of symp-
toms generally ranged from 5 to 10 days, with no apparent
long-term sequelae.3
More outbreaks of Zika virus occurred in the Pacific Is-
lands region from 2013 to 2014. An epidemic in French Poly-
nesia included the first published cases of Zika virus–related
Guillain-Barré syndrome.4 By 2014, Zika virus had spread to
South America, and an association with Guillain-Barré syn-
dromewas reported in Brazil.5 In addition, the alarming new
finding of cases of microcephaly was reported in the infants
of Zika virus–infected mothers.6 The current scientific con-
sensus is that Zika virus was the likely cause ofmicrocephaly
in these infants.7 Since May 2015, Zika virus has spread from
South America to Central America, Puerto Rico, the United
States, and the US Virgin Islands.More than 1million cases of
Zika virus infection have been reported in Central and South
America. In addition, theneurologicmanifestations of this vi-
ral infectionare still evolving. Therefore, theWorldHealthOr-
ganization declared Zika virus infection to be a Public Health
Emergency of International Concern.8 However, in Novem-
ber 2016, the World Health Organization changed the decla-
rationof Zikavirus infection as apublic health emergency and
stated that the Zika virus outbreak and related clusters ofmi-
crocephaly are no longer a Public Health Emergency of Inter-
national Concern. This change in the declaration does not
downgrade the importance of Zika virus but designates it as a
focus for a long-term program of work.9
Diagnosis of Zika virus infection is problematic owing to
the similar presentation of the virus to other flaviviruses, its
self-limitednature, and its serologic cross-reactivitywithother
flaviviruses. Polymerase chain reaction assays candetect Zika
virus RNAwithin the first week of infection but have limited
usefulness beyond that time frame. Serologic testing for Zika
virus IgMhashighcross-reactivitywithother flaviviruses.The
plaque reduction neutralization test has greater specificity.10
In Colombia, a country with a population of 48 million,
Aedes aegypti andAedes albopictusmosquitoes aremost com-
monly found at elevations below 2000 m. A recent prelimi-
nary report by Pacheco et al11 found that before April 2016,
65 726 cases of Zika virus infection were reported in Colom-
bia. Transmission of the Zika virus frommother to fetus and
sexual transmissionhavebeen reported. The first outbreak of
Zika virus infection in continental SouthAmerica occurred in
Brazil, where autochthonous transmission was confirmed in
May 2015. Although preliminarymonitoring began in Colom-
bia after recognition of theBrazilian outbreak, theColombian
InstitutoNacional de Saludbeganofficial surveillance for Zika
virus infection in August 2015.11-14
In Venezuela, a country with a population of 30million, a
recent report by the Venezuelan Society of Public Health esti-
mates that the number of probable cases of Zika virus infec-
tion from2015 to thebeginningofApril 2016was723550 (23.6
per 1000 population), with hundreds of these cases occurring
with Guillain-Barré syndrome.15 Although severe ocular com-
plications have not been reported, tertiary ophthalmic clinics
have observed severe multiple complications beyond typical
conjunctivitis after symptomatic infection typical of the Zika
virus.15,16However, theprevalenceofZikavirus infection inCo-
lombiaandVenezuela is stillpresumptivebecausedefinitivese-
rologic testingforZikaviruswasnotavailableat thetime.There-
fore, theprevalenceofZikavirus infectioncitedherein includes
all the patients who were reported to the National Institute of
Health in Colombia and Venezuela with symptoms of Zika vi-
rus infection with andwithout laboratory confirmation.
Microcephaly can be genetic, metabolic, drug related, or
due to perinatal insults, such as hypoxia, malnutrition, or in-
fection. The 20-fold increase in cases of microcephaly
reported inpartsofBrazil is temporallyassociatedwith theout-
breakof Zika virus.However, this association is still presump-
tive because definitive serologic testing for Zika viruswasnot
available inBrazil at the timeof theoutbreak andother causes
of microcephaly may also have been mistakenly included.17
Other reports have been published on patients with Zika vi-
rus infectionwith ocularmanifestations.17,18 An evaluationof
58 eyes in 29 infants by de Paula Freitas et al16 indicated bi-
lateral findings in 7 of 10 patients with ocular lesions, with a
prevalence of 34.5%.Recently, a case of glaucoma in apatient
with congenital Zika syndromewas reported.19 The objective
of the present study is to report the ophthalmic manifesta-
tions in infants with congenital Zika syndrome inMaracaibo,
Venezuela, and Cúcuta, Colombia.
Methods
This prospective case series evaluated 43 infants with con-
genital Zika syndrome at Clinica de Ojos in Maracaibo, Ven-
ezuela, and Clinica Oftalmológica Peñaranda in Cúcuta, Co-
lombia. Ophthalmic evaluation was performed fromOctober
1, 2015, through June 30, 2016. This study was approved by
Key Points
Question What are the ophthalmic manifestations in infants with
microcephaly associated with clinically diagnosed Zika virus in
Colombia and Venezuela?
Findings In this case series of 43 patients, substantial anterior and
posterior segment abnormalities, including congenital glaucoma,
were found in 5 (12%) andmacular or optic nerve abnormalities in
38 (88%).
Meaning These findings suggest that all infants with
microcephaly associated with clinically diagnosed Zika virus should
undergo evaluation for ophthalmic findings.
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the institutional ethics committee at both study centers.Writ-
ten informedconsent for this studywasobtained fromthepar-
ents of all infants. The study and data collection adhered to
the tenets of the Declaration of Helsinki.20
All infants and mothers underwent systemic and retinal
examinations and documentation with fundus imaging. In-
clusion criteria consisted of mothers with suspected Zika vi-
rus infection and a cephalic circumference of 32 cm or less at
birth. Other congenital infections included in the differential
diagnosis were TORCH, which includes toxoplasmosis, other
infection (syphilis, varicella-zoster, or parvovirus B19), ru-
bella, cytomegalovirus infection, andherpes simplexvirus in-
fection, andhuman immunodeficiencyvirus infection. These
diseaseswere ruledout through serologic testing. In all cases,
specific testswereperformedaspart of routine screening that
included serologic testing ofmothers. The suspected diagno-
sis of congenital Zika virus infection was also based on clini-
cal features of themothers during pregnancy, including cuta-
neous rash, fever, arthralgia, headache, itch, and malaise.
Newborn infants were excluded if they had a cephalic di-
ameter that exceeded 33 cm, evidence of other congenital in-
fections such as TORCH or human immunodeficiency virus,
or a familial history of microcephaly. All mothers underwent
anexternalocular examination,biomicroscopy, anddilated in-
direct ophthalmoscopy. All infants underwent an ocular ex-
ternal examinationand indirectophthalmoscopy.Opticnerve,
retinal, andchoroidalabnormalitiesweredocumentedwithuse
of a wide-field digital imaging system (RetCam Shuttle; Clar-
ity Medical Systems, Inc) after pupillary dilation.
Data were collected in an Excel 2011 spreadsheet (Micro-
soft Corp) and statistically analyzed with MedCalc software
(version 8.2.0.3; MedCalc). Continuous data are presented as
means and categorical data as numbers and percentages. Pa-
tients’ cup-disc ratio and corneal diameter were transferred
from their records and converted to means for analysis. We
used thepaired t test to comparemeanvalues.Correlationwas
considered significant with P < .05. The 95% CIs were calcu-
lated using assumptions based on the Poisson distribution.
Results
Forty-three infants withmicrocephaly, ocular findings, and a
clinical diagnosis of Zika virus vertical infection underwent
evaluation. Mean (SD) age on the day of the examinationwas
2.1 (1.5) months (range, 0.2-6.6 months). Twenty-eight pa-
tients (65%)were female, and 15 (35%)weremale. Twentypa-
tients were Hispanic; 13, of African descent; 8, white; and 2,
of Native American origin. All the patients were born during
theZikavirusoutbreak inColombia andVenezuela, andall the
mothers were clinically diagnosed with Zika virus infection,
defined by denguelike symptoms (malaise, rash, and arthral-
gia) during pregnancy. Thus, the infants were clinically diag-
nosed with presumed intrauterine Zika virus infection (con-
genital Zika syndrome). Infants with microcephaly with a
presumed diagnosis of congenital Zika syndrome were re-
cruited through an active search and referrals fromother hos-
pitals andhealth centers.Noneof themothers presentedwith
any ocular findings. All infants presented with bilateral ocu-
lar findings.Five infants (12%)hadhypoplasiaof theopticnerve
with the double-ring sign, pallor, and increased cup-disk ra-
tio (Figure 1). Themacular abnormalities weremild to severe
pigment mottling in 27 infants (63%) (Figure 2) and lacunar
maculopathy in 3 (7%), defined as diffuse lacunar chorioreti-
nal dysplasia. Chorioretinal scarring was present in 3 infants
(7%) (Figure 3). Eleven patients (26%) had a combination of
Figure 1. Optic Nerve Hypoplasia
Representative ophthalmoscopy in the left eye of a patient with congenital Zika
syndrome demonstrates optic nerve hypoplasia with the double-ring sign (open
triangle) and disc pallor.
Figure 2. Severe PigmentMottling
Patient AA Patient BB
Representative ophthalmoscopy in
the left eyes of 2 patients with
congenital Zika syndrome
demonstrates macular chorioretinal
atrophy (open triangles) and focal
pigment mottling (arrowheads).
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lesions in the posterior pole. Five infants (12%) had congeni-
tal glaucoma characterized by the clinical triad of epiphora,
photophobia, andblepharospasm; increased intraocular pres-
sure to a mean of 57.4 mmHg (range, 49.8-76.1 mmHg); cor-
neal clouding at birth; and buphthalmos (enlargement of the
eye) (Figure 4 and Table). In total, 12% (95% CI, 5%-24%) of
cases had anterior segment abnormalities, and 88% (95% CI,
76%-94%)had importantmacular andoptic nerve abnormali-
ties. No other retinal manifestations were found. The retina
remainedattached inall cases.Nocasesofanterioruveitiswere
found in this series of patients.
Discussion
This studyof theophthalmicmanifestationsof congenital Zika
syndrome found various abnormalities. These findings in-
cludedfocalpigmentmottlingwithapredilectionfor themacu-
lar area, optic disc hypoplasia, lacunarmaculopathy, and cho-
rioretinal scars. In the present study, 5 infants presentedwith
congenital glaucoma associated with Zika virus infection.
To our knowledge, this case series is the first to report con-
genital glaucoma associated with congenital Zika syndrome.
de Paula Freitas et al19 recently reported the first case of glau-
comaassociatedwith congenital Zika syndrome.Basedonour
findings, we agreewith de Paula Freitas et al16 that all infants
with microcephaly should undergo a routine ophthalmic ex-
amination, and every infant with microcephaly in countries
with a high prevalence of Zika should undergo evaluation for
abnormal ocular changes.
Zika virus is a mosquito-borne flavivirus transmitted by
A aegypti and A albopictus, which are also vectors for dengue
andchikungunya.Theemergenceof Zikavirusworldwide, es-
pecially in tropical countries including Venezuela, coincided
with increased reports of newborns with microcephaly, con-
genital malformations, and neurologic syndromes. The dec-
larationonZikavirusby theWorldHealthOrganization inFeb-
ruary 2016 was to the result of the rapid spread of Zika virus
infection. Therefore, only caseswithmicrocephalywere clas-
sified aspresumedcasesof congenital Zikavirus infectionand
further investigated.16 A recent case report proposes thatmi-
crocephaly should not be a required criterion for diagnosing
congenital Zika virus infection.17
Zikavirus infectioncausesa self-limiteddenguelike illness
characterizedbyexanthema, low-gradefever,conjunctivitis,and
arthralgia, although itmaybeasymptomatic in somecases.17,18
Someoftheophthalmicfindingsinthepresentstudyconcurwith
thoseofpreviousreports.19,21,22Forexample,chorioretinal scar-
ring in themacular regionhas been reported in congenital Zika
virusinfection.17dePaulaFreitasetal16described17eyesaffected
byZikaviruswithmicrocephaly; ophthalmic findings included
focalpigmentmottling,chorioretinalatrophy,opticnerveabnor-
malities, iriscoloboma,andlenssubluxation.Ourfindingofcon-
genital glaucoma in association with an epidemic of systemic
disease is similar to the experience with congenital rubella
syndrome.23 A follow-up study of 125 patientswith congenital
rubellasyndrome23evaluatedtheassociationbetweenophthal-
micdisorders andsystemicdiseaseand reported that9%of the
patientshadcongenital glaucoma.Transplacental transmission
ofWest Nile virus has been previously reported,24 resulting in
lesionssomewhatsimilartothosedescribedinthepresentstudy,
suchasmaculargranularappearanceandchorioretinal scarring.
Thedifferential diagnosisof chorioretinal lesions suchas those
Figure 3. Chorioretinal Scarring
Representative ophthalmoscopy in the left eye of a patient with congenital Zika
syndrome demonstrates a chorioretinal scar with macular retinal pigment
epithelium hypopigmentation and scarce pigment surrounding 2 sharp areas of
hypopigmentation (lacunae) with pigmentation in their borders and 250 μm
and 500 μm in size.
Figure 4. Bilateral Congenital Glaucoma
Right eyeA Left eyeB
A patient with bilateral congenital
glaucoma had the clinical triad of
epiphora, photophobia, and
blepharospasm; increased intraocular
pressure; corneal clouding at birth;
and buphthalmos in both eyes.
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reported in this series includesmany other infections, such as
toxoplasmosis, cytomegalovirus infection, rubella,herpessim-
plexvirus infection,andsyphilis.However, these infectionsare
easily ruled outwith neonatal testing.
Limitations
Ourstudy is limitedby its retrospectivenatureand the fact that
themotherswereclinicallydiagnosedashavingZikavirus infec-
tionbasedonpersonalhistory. Inaddition, clinical criteriawere
usedtodiagnoseZikavirus infection,andthediagnosiswaspre-
sumptive. Furthermore, our study evaluated the ophthalmic
manifestations incongenitalZikasyndromewithmicrocephaly.
Of note,microcephaly is not required for the diagnosis of con-
genitalZikasyndrome.Therefore,ocular featuresmayhavebeen
missedbecauseof this exclusioncriteria.However, thepopula-
tion sample of this study is representative of a random sample
of theColombianandVenezuelanpopulations living inhotand
humid areas below an altitude of 2000m. Furthermore, these
infantswerebornafteraZikavirusoutbreakinColombiaandVen-
ezuela.This studypresentspreviouslyunreportedocular find-
ings in congenital Zika syndrome for the region.
Conclusions
Forty-three infants with congenital Zika syndrome had se-
vere ocular abnormalities, and all patients had bilateral in-
volvement. The posterior ocular findings were focal pigment
mottling, chorioretinal atrophy with a predilection for the
macular area, congenital glaucoma and optical nerve hypo-
plasia, andopticdiscabnormalities.Ourdata revealed that 12%
(95% CI, 5%-24%) of cases of congenital Zika with micro-
cephalyhadanterior segment abnormalities and88%(95%CI,
76%-94%)had importantmacular andoptic nerve abnormali-
ties.Ophthalmicexamination is recommended inpatientswith
congenital Zika syndrome.
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Table. Findings at Presentation and After Treatment of PatientsWith Congenital Glaucoma
Patient
No./Age,
mo
Examination 2-mo Follow-Up
IOP, mm Hg
IOP During
Follow-up,
mm Hg
Mean
Cup-Disc
Ratio Findings Treatment
IOP During
Follow-up,
Range (Mean),
mm Hg
Corneal
Diameter,
Range
(Mean), mm
Mean
Cup-Disc
Ratio Findings
1/4.5 OD, 44.5;
OS, 46.4
OD, 13.1;
OS, 13.0
OD, 0.7;
OS, 0.7
Epiphora,
photophobia,
blepharospasm, no
anterior uveitis, and
corneal enlargement
and edema
Combined
trabeculotomy
and
trabeculectomy
OD,
17.2-21.3
(19.25);
OS, 16.5-22.4
(19.45)
OD,
12.9-12
(12.45);
OS,
12.8-12.1
(12.45)
OD, 0.7;
OS, 0.7
Corneal scar and
haze, optic nerve
atrophy
2/3.1 OD, 49.8;
OS, 50.9
OD, 12.2;
OS, 12.0
OD, 0.7;
OS, 0.7
Epiphora,
photophobia,
blepharospasm,
no anterior uveitis,
buphthalmos, and
corneal enlargement
and edema
Combined
trabeculotomy
and
trabeculectomy
OD,
12.4-17.4
(14.9);
OS, 13.6-16.1
(14.8)
OD,
12-11.7
(11.85);
OS,
11.9-11.5
(11.7)
OD, 0.7;
OS, 0.7
Corneal scar
and haze
3/6.6 OD, 76.1;
OS, 70.1
OD, 13.0;
OS, 12.9
OD, 0.8;
OS, 0.8
Epiphora,
photophobia,
blepharospasm,
no anterior uveitis,
buphthalmos,
corneal enlargement
and edema, and Haab
striae
Combined
trabeculotomy
and
trabeculectomy
and 1
IOP-lowering
medication
OD,
21.4-22.5
(21.9);
OS, 18.4-19.3
(18.8)
OD,
12.5-12.5
(12.5);
OS,
12.7-12.5
(12.6)
OD, 0.8;
OS, 0.8
Corneal scar and
haze, optic nerve
atrophy, Haab
striae
4/2.1 OD, 65.5;
OS, 46.7
OD, 12.6;
OS, 12.8
OD, 0.7;
OS, 0.7
Epiphora,
photophobia,
blepharospasm,
no anterior uveitis,
buphthalmos,
corneal enlargement
and edema, Haab
striae, and optic disc
cupping
Combined
trabeculotomy
and
trabeculectomy
OD, 16.8-21.2
(19);
OS, 12.7-18.9
(15.8)
OD,
12.1-11.9
(12.0);
OS,
12.4-12.3
(12.35)
OD, 0.7;
OS, 0.7
Corneal scar and
haze, Haab striae
5/1.8 OD, 51.1;
OS, 72.9
OD, 12.9;
OS, 12.9
OD, 0.7;
OS, 0.7
Epiphora,
photophobia,
blepharospasm,
no anterior uveitis,
buphthalmos,
corneal enlargement
and edema, and Haab
striae
Combined
trabeculotomy
and
trabeculectomy
OD,
14.4-16.9
(15.6);
OS, 18.3-19.1
(18.7)
OD,
12.7-12.6
(12.65);
OS,
12.0-12.0
(12.0)
OD, 0.7
OS, 0.7
Corneal scar and
haze, optic nerve
atrophy, Haab
striae
Abbreviation: IOP, intraocular pressure.
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